Proteoheparan sulfate can be adsorbed onto a methylated silica surface in a monomolecular layer via its transmembrane hydrophobic protein core domain. Due to electrostatic repulsion, its anionic glycosaminoglycan side chains are stretched out into the blood substitute solution, thereby representing a receptor site for specific lipoprotein binding through basic amino acid-rich residues within their apolipoproteins. The binding process was studied by ellipsometric techniques suggesting that HDL has a high binding affinity and a 21 protective effect on interfacial heparan sulfate proteoglycan layers with respect to LDL and Ca complexation. LDL was found to be 21 deposited strongly at the proteoheparan sulfate-coated surface, particularly in the presence of Ca , apparently through complex formation 'proteoglycan-low density lipoprotein-calcium'. This ternary complex build-up may be interpreted as arteriosclerotic nanoplaque formation on the molecular level responsible for the arteriosclerotic primary lesion. In a receptor-based biosensor application, this system was tested on its reliability to unveil possible acute pleiotropic effects of the lipid lowering drug fluvastatin. The VLDL / IDL / LDL and VLDL / IDL / LDL / HDL plasma fractions from a high risk patient with dyslipoproteinaemia and type 2 diabetes mellitus showed the start 21 21 of arteriosclerotic nanoplaque formation at a normal blood Ca concentration, with a strong increase at higher Ca concentrations. Nanoplaque formation and size of the HDL-containing lipid fraction remained well below that of the LDL-containing lipid fraction. Fluvastatin, whether applied acutely to the patient (one single 80 mg slow release matrix tablet) or in a 2-month medication regimen, markedly slowed down this process of ternary aggregational nanoplaque build-up and substantially inhibited nanoplaque size development 21 at all Ca concentrations used. The acute action gave no significant change in lipid concentrations of the patient. Furthermore, after nanoplaque generation, fluvastatin, similar to HDL, was able to reduce nanoplaque formation and size. These immediate effects of fluvastatin have to be taken into consideration when interpreting the clinical outcome of long-term studies.
. Introduction
probably initiated in response to a variety of vascular 'insults', including hypercholesterolaemia, hypertension, Nowadays, arteriosclerosis is not considered as a sepadiabetes and smoking [1] . The process involves lipid rate entity but in the context both of its multifarious history accumulation, proliferation and migration of macrophages of origins and its multiplex irradiation into cardiovascular and smooth muscle cells and acquisition of a layer of clinical pictures. Correspondingly, arteriosclerosis itself is connective tissue which covers the mature plaque. This an inflammatory and a fibroproliferative process that is mechanistic framework for atherogenesis is important for visualizing the role of dyslipidaemia and the other coronary heart disease (CHD) risk factors in creating a vascular milieu prone to disease, and increasingly the solution. The normal blood substitute solution consisted of synergistic effects of multiple risk factors have been of a Krebs solution simulating the extracellular ionic miinterest. Bearing this in mind, it is not astonishing that croenvironment of the proteoglycans and lipoproteins, and pleiotropic mechanisms of action which we are just 1.38 mmol / l (25 8C, pH 7.27). Normally, the solution was unveiling. Statins inhibit a cholesterol synthesis enzyme aerated with a 95% O / 5% CO gas mixture (carbogen).
2 2 (CSE) leading to a lowering of low-density lipoprotein Krebs solutions containing LDL were gassed by 93% (LDL) levels. This is the principal mechanism. Based on N / 7% CO to hinder LDL oxidation [8] .
2 2 this alone, however, neither the great success of clinical Native proteoheparan sulfate (HS-PG) from the bovine trials in patients with stable CHD and in CHD risk aorta has a relative molecular mass of about 560 kDa, individuals nor the effects on other symptoms and risk 11.6% of which is protein (M¯400 kDa). It has a few r factors can be explained [2] . heparan sulfate (HS) side chains (88.4%) in covalent The present communication elucidates results from a bonding (mol. wt. 35-38 kDa) with an average sulfate clinical trial which led to the discovery of a further content of 0.5 mol sulfate / disaccharide unit [9, 10] . pleiotropic statin effect, that is the immediate intervention Fasting blood samples from a high risk patient not yet of fluvastatin into plaque formation and disintegration at treated with lipid-lowering agents in a clinical trial proving the very earliest stages of arteriosclerosis development.
the efficacy of fluvastatin in hyperlipidemic patients with Nanoplaque build-up and estimate of its size could be type 2 diabetes mellitus was taken via an EDTA-Sarstedt pursued by ellipsometric techniques using an established monovette in a medical practice. In the evening of the molecular model for arteriosclerosis [3] [4] [5] , that was tested same day, this patient took one slow release matrix tableẗ in a biosensor application with the lipid fractions of CSEof fluvastatin 80 mg (Novartis Pharma, Nurnberg, Gerinhibitor-treated patients. Since the initial lipid deposition many) for the first time [11] . The next morning, after steps in atherogenesis are surface-related phenomena at approximately 10 h, a blood specimen of the patient was endothelial cells and vascular matrices, we carried out this obtained again in order to detect a possible immediate investigation on the adsorption of lipoproteins in order to effect of fluvastatin after its processing in the body of the learn more about their interfacial behaviour. Hydrophobic patient. A further blood sample was derived from the same silica surfaces were modified through adsorption of patient after 2 months of continuous therapy in order to proteoheparan sulfate, the latter substrate thus mimicking separate out a long-term from a short-term effect of the the surface receptors exposed to lipoproteins in the blood statin. stream or on their paracellular pathway [4, 6, 7] . In order to Blood samples were allowed to cool to room temperaobtain information on some biological relevance, an imture for 10 min, centrifuged at 4000 rpm for 10 min, and portant aspect of the present investigations was to perform plasma supernatants carefully pipetted into small polythese experiments at close to in vivo conditions. The ethylene tubes. Thereafter, lipoproteins were isolated by results of an acute intervention of fluvastatin, independent sequential preparative ultracentrifugation essentially as of any lipid lowering effect, into arteriosclerotic nanopdescribed previously [12] . The following densities were laque build-up using the plasma of a high risk patient with used: d,1.063 kg / l for the preparation including very low type 2 diabetes mellitus from a clinical trial are highlighted density lipoproteins (VLDL), intermediate-density lipoproand discussed in the present study and contrasted with the teins (IDL) and LDL, and d,1.21 kg / l for the preparation results of long-term treatment of the same patient.
including VLDL, IDL, LDL and high-density lipoproteins (HDL). All centrifugation steps were carried out at 18 8C using partially filled polycarbonate bottles (6 ml) in a 50
. Methods
Ti rotor. Both preparations were then dialyzed against phosphate-buffered saline (PBS) to eliminate salt and This was part of a double-blind, randomized, placebo-EDTA. All samples were collected in small glass tubes (2 controlled, 12-week study comprising a 4-week dietary ml) and treated with a continuous flow of nitrogen before run-in phase followed by a study treatment period of 8 closure with a metallic screw cap in order to minimize weeks, which was conducted at 10 centres in Germany.
lipid oxidation. Cholesterol and triglycerides were deThe study protocol was approved by the Ethics Committee termined enzymatically with the CHOD-PAP and the GPOof the University of Freiburg, Germany, and the institu-PAP method (Wako Chemicals, Japan), respectively. Contional review boards at each study centre. All patients gave centrations of apolipoproteins were determined by turtheir informed, written consent.
bidimetry on an Olympus A640 analyzer (Olympus, Tokyo, Japan) using polyclonal antisera (Rolf Greiner 2 .1. Preparations and solutions Biochemica, Germany) specific for the respective antigens. Prior to the ellipsometry investigations, the lipoprotein All experiments were carried out in a blood substitute fractions were again run through a chromatography column (Econo-Pac Column 732-2010, Bio-Rad, Hercules, CA, [5, 19, 21] . Lipoprotein particles or cations may interact USA) filled with Krebs buffer solution and finally applied with the GAG chains, e.g. on occasion of their positive to the experiment in their natural patient blood concenamino acid residues or simply their positive charges. Thus, trations. At the end of each experiment, fluvastatin (2.2 the situation reflects physiological conditions, since, for mmol / l) was administered to discover a possible disexample in the endothelial cell membrane, the scenario integrating effect on ternary nanoplaque complexes. differs only in one respect, that the short hydrophilic intracellular core domain is located in the cell interior. In 2 .2. Ellipsometry measurements this sense, the hydrophobic silica surface simulates the cell membrane overlaid with the glycocalyx quite perfectly. The adsorption of the lipoproteins and of proteoheparan Furthermore, in this in vitro model, any drug can be tested sulfate was monitored by in situ ellipsometry, as detailed with respect to its antiarteriosclerotic potential [5] . previously [13] [14] [15] . All measurements were carried out
With the following experiments, we wanted to evaluate with a Rudolph 436 thin film ellipsometer at 401 nm. In the applicability of the molecular model for nanoplaque summary, the optical response of the bare surfaces was formation in the clinical situation. Within a clinical study first investigated, whereafter the proteoglycan or lipoproinvestigating the effectiveness of fluvastatin on lipoprotein tein was added and changes in the state of polarization of subfractions in high-risk patients with type 2 diabetes the reflected light were monitored. The adsorbed amount mellitus, the blood of a patient was taken before, after 10 h was determined according to de Feijter using a refractive therapy with a single dose of fluvastatin and after 2 months 3 index increment of 0.18 cm / g [16] . A bulk concentration therapy with a single dose of fluvastatin daily (Table 1) , of approximately 0.1 mg / ml proteoheparan sulfate (0.192 and the in vivo-concentration of the VLDL / IDL / LDLmmol / l in disaccharide units) was used [5] . Furthermore, fraction applied in our assay [22, 23] . The ternary complex 21 21 the measurements were carried out at different Ca build-up was then pursued through increasing the Ca concentrations around that in the biological system. The concentration. The sample from the patient treated once a normal blood substitute solution consisted of a Krebs day was used in the experiment after the usual preparation solution. The pH was kept between 7.25 and 7.30 by the and double-dialysis in order to prove a possible acute bicarbonate / phosphate buffer, and by the continuous aeraeffect of fluvastatin after its processing in the human body. tion of the cuvette solution with a 95% O / 5% CO At the end of the experiment, control and test samples Sweden). The latter is included due to the necessity to keep after formation of the ternary nanoplaque complex. the pH well regulated during these experiments in order to Shown in Fig. 1 is the adsorption of VLDL / IDL / LDL avoid both proteoglycan and lipoprotein degradation and at a HS-PG coated surface. As can be seen, the adsorption 21 calcium phosphate precipitation. The adsorption was caris limited in the absence of Ca , at least for a considerried out at 25 8C throughout. Further details can be found able time. Opposite to this limited adsorption, in the 21 in previous publications [17, 18] . presence of the physiological serum concentration of Ca (Ca1: 2.52 mmol / l), the deposition is strongly accelerated in the control experiment (by 67%) and so much the more 21
. Results
with twice the normal Ca concentration (by 103%), whereas upon fluvastatin medication, a moderate reduction Proteoheparan sulfate deposition at a methylated silica in ternary complex deposition was measured (cf. Fig. 3A which is related to the molecular size of the ternary aggregational complexes did not markedly increase upon application, the steep increase in nanoplaque formation and Ca1, but prominently upon Ca2 additions, in complete deposition started, in parallel with a large scatter of the accordance with former experiments in the absence of measuring points (Fig. 1) . The scatter reflects the heteroproteoglycan coating of the silica surface [5] and with light geneity in particle size of the aggregational ternary comscattering experiments [8] , where the adsorbed amount and plexes. The shape of the curve orients itself by the G-mean particle size, respectively, increased significantly with Ca2 21 values at the respective Ca concentrations, and was incubation. In the case where the patient was treated with calculated using an algorithm for least-squares estimation only one fluvastatin tablet for 10 h, the adsorbed layer of nonlinear parameters [24] . comparatively minor increase only for very high Ca the control curve. Furthermore, the dramatic reduction in concentrations. Noteworthy is the rise in ternary nanopnanoplaque size compared to the initial values is especially laque deposition upon first application of fluvastatin at the prominent after 2 months of therapy. This applies par- 21 end of the control experiment, whereas in the test experiticularly to Ca concentrations up to 10.08 mmol / l. ment with the lipid fraction exposed to a single dose of Finally, the strong rise in adsorbed layer thickness at the fluvastatin only, there occurred no increase worth mentionend of the control experiment during the first fluvastatin ing (Fig. 1) . On the contrary, there was a decrease in incubation ran parallel to an equal increase in total ternary proteoheparan sulfate-lipoprotein-calcium comadsorbed amount. On the other hand, a more or less plex deposition after the interaction with fluvastatin for 15 marked reduction in size of the ternary nanoplaque commin in the sample from the patient prepared after the plex appeared in the lipid fraction processed by a single intake of a single dose fluvastatin.
tablet in the patient. These findings were confirmed by measuring the thick-
The investigations with a lipoprotein fraction from a ness of the interfacial layer (Fig. 2) . In the control high-risk patient emphasized that short-and long-term experiment, the adsorbed layer thickness formation and the size development of ternary nanoppicture impressively shows that the steep increase in 21 21 laques, and this even at high Ca concentrations. Fig. 4 nanoplaque formation was shifted to higher Ca conillustrates the extent of inhibition. There arose a similar centrations upon a longer duration of treatment and that curve profile for the reduction in adsorbed amount of fluvastatin was able to dissolve freshly formed nanop- 21 ternary nanoplaques dependent on the Ca concentration laques. When fluvastatin was added for the first time in the used, not only for the VLDL / IDL / LDL lipoprotein fraccontrol curve, the ternary complex formation did not tion processed by fluvastatin in the body of the patient on a increase (cf. Fig. 1 , VLDL / IDL / LDL: 1210%) but delong-term scale but also upon a 1-day exposure time. The crease (cf. Fig. 5 , VLDL / IDL / LDL / HDL: 215%) within degree of inhibition varied between 17 and 76%. Similar 30 min. Thus, HDL and fluvastatin seem not only to hinder results were found for the reduction in adsorbed layer partially the process of nanoplaque formation but also to thickness, although nanoplaque size was only moderately reverse it to some extent. Additionally, it appeared that the 21 diminished in normal serum Ca . On the other hand, a reaction of the docking process of the lipid fraction to the continuous diminution of nanoplaque size was measured proteoglycan receptor followed HDL-type kinetics, that is 21 with increasing Ca concentrations. Moreover, the peak an initial simple-exponential desorption [4] . These results 21 inhibition seemed to be shifted to higher Ca concenare confirmed in Fig. 6 , where the adsorbed layer thickness trations after long-term medication. In total, the inhibition of the ternary aggregational complexes was recorded. ranged between 4 and 67%. Furthermore, it should be Again, it is clear that there is a strong correlation between 21 stressed that the addition of fluvastatin at the end of the duration of statin treatment and Ca concentration where experiments led to a drastic decline in adsorbed amount nanoplaque size has been strongly promoted. and layer thickness.
The graphs in Fig. 7 show nanoplaque formation (A) and 21 In order to corroborate the fluvastatin effect raised with size (B) as a function of Ca concentration, where the the VLDL / IDL / LDL-fraction and to demonstrate both the initial amounts for the dimeric complex proteoglycan / ) and underwent only a curve was measured again. Fluvastatin was added at the small further decrease after 2 months of medication end of the experiment to examine whether arteriosclerotic (222.6%). In plaque size, however, a further marked nanoplaques were resolvable after their build-up. This decrease took place after long-term therapy (232.3%) were 260.6613.9, 127.467.8 and 44.763.7 mg / dl, respecThe longer the fluvastatin therapy lasted, the trend to a right shift of the steep rise in nanoplaque formation and 21 size to higher Ca concentrations was repeatedly emphasised.
The reductions as calculated as a ratio to the control values in question (Fig. 7, s) are represented quantitatively in Fig. 8, i .e. for nanoplaque formation in the upper part, 21 and for plaque size in the lower part. With normal Ca concentration, new nanoplaques were formed to a roughly 40% less extent (1-day treatment: 238.3%; 2 months treatment: 241.9%), however, nanoplaque size was reduced by 9.9% after 1 day treatment and by 26.0% after 2 months medication. After this long-term therapy, the maxima in reductions of both amounts were shifted to a 21 higher Ca concentration of about 10 mmol / l. Here, it shall be mentioned that the effects of a 2-month therapy with fluvastatin collected from seven patients of the same high-risk patient collective showed the same tendency to tional change, so that the pitch of turns is compressed Stretches of basic amino acid-rich residues within apoB, [10, 21, 30] . Simultaneously, the cooperativity of this dual apoA and apoE constituting the predominant protein complex may be amplified by allosteric lipoprotein dockmoiety of LDL and HDL display a high electrostatic ing to that shortened conformation supported by the higher binding affinity to proteoglycans. In the proteoheparan charge density and fitting stereospecificity. Thus, the sulfate perlecan, the large protein core carries three HS heterotrimeric complex would become rather stable. The chains of 30-70 kDa which are 100-170 nm in length and adsorption to the silica surface may be promoted. This, covalently attached to Ser-Gly consensus sequences clushowever, is rather speculative and not known at present. It 21 tered at the N terminus [25] . This major HS-attachment is equally possible that deposition through Ca -dependent domain I is considered to be a putative lipoprotein binding complex formation between the lipoproteins and HS-PG is site for reasons of electrostatic attraction [26] . Immediately likely to occur and contribute to the observed effects. adjacent, domain II contains four copies of LDL receptor With respect to the lipoprotein fractions used in our repeats and one immunoglobulin repeat (NCAM module) experiments, the question arises whether these concen- [27] . Also such motifs in perlecan are thought to mediate trations are relevant within the scenario studied. On the LDL binding for reasons of core protein receptor moduleone hand, HS-PGs are integral constituents of the plasma lipoprotein ligand interactions. Interestingly, the expression membrane of endothelial cells (e.g. syndecans) and, on the of the proteoglycan in endothelial cells is modulated by other hand, of the extracellular matrices (e.g. perlecan, LDL [28] . Full-blown arteriosclerotic plaques as clinically fibroglycan). In the first case, our model is adequately detected by spiral computer tomography and magnetic suited because we used the lipoprotein fractions at their resonance imaging basically contain lipoproteins associnatural patient blood concentration, and these could interated with proteoglycans of high diversity and versatility act with the proteoglycan receptor. For the second case, it and complexly aggregated with high amounts of calcium should be critically mentioned that the lipoprotein ratio [29] . Therefore, the replica in nanoscale dimensions of the applied probably does not correspond to the in vivo heterotrimeric aggregational complex consisting of proteorelations in the extracellular matrix of the vessel wall.
deduced from Figs. 5-7 as a significantly diminished nanoplaque formation and size compared to the related curves without HDL, a further indication for the strong binding of HDL to the proteoglycan receptor. In order to be able to additionally compare the fluvastatin effect with the HDL effect, we had carried out all the experiments with the whole lipoprotein fraction of the patient and one devoid of HDL. The courses of the corresponding curves in each set of experiments behave very similar in principle, however, the absolute values of adsorbed amount and layer thickness of the VLDL / IDL / LDL fraction are in total approximately twice as high as for the HDL-containing fraction. Comparing the results of both experimental series for normal serum calcium with each other as well as with the fluvastatin effect in the HDL-containing experiments led to the surprising fact that fluvastatin was at least 3.5 times more powerful in our patient than his own HDL to prevent arteriosclerotic nanoplaque formation and growth, whereas both agents were about equally effective in nanoplaque size inhibition. Taking together these findings on the HDL / LDL-interplay at their receptor binding site with the results from previous experiments illustrate that HDL is able not only to hinder the formation of the ternary complex HS-PG / 21 LDL / Ca but also to probably disintegrate such a primary lesion nanoplaque [5, 32, 33] . We had just worked out that in our high-risk patient, the potency of fluvastatin is in no way inferior to the efficacy of HDL and even exceeds concentration, the great majority of the peripheral proteoglycan receptors both on and in the arterial vascular wall Based on different sizes of the lipoprotein particles and are supposed to be occupied by HDL particles and thus since molecular sieving takes place at the endothelial LDL uptake limited. In addition to the three known barrier, the lymph / plasma concentration ratios vary from antiatherogenic action principles of HDL, namely inhibi-0.03 for VLDL sized particles to 0.3 for HDL sized tion of monocyte adhesion and LDL oxidation as well as particles [31] . These ratios indicate that blood concenmediation of cholesterol efflux, a fourth beneficial forechtrations are likely to be much higher than concentrations in ecking mechanism is active which effectively controls the extracellular matrix of the vessel wall. Since we cholesterol influx into the vascular wall via the transwanted to exemplarily show with our experiments that endothelial and paraendothelial pathways. Therefore, internanoplaque formation and size can be restricted by fluvascellular LDL diffusion into the subendothelial matrix tatin treatment, the results should be correlated with the in spaces is neither an open flank within an ingenious control vivo situation.
system nor the internalization of LDL as a prerequisite to The HDL effect as disclosed through comparison of the the transendothelial transport. Both, cholesterol entry and corresponding curves in Figs. 1 and 5, may be interpreted exit, are powerfully checked via feedforward and feedback as an indication that HDL strongly counteracts primary loops (competition at the receptor site; expression of the lesion generation in the form of the ternary complex, proteoglycan receptor; posttranslational modification of the proteoglycan-LDL-calcium. Furthermore, it was derived GAG side chains). Only if LDL increasingly occupies from earlier experiments that HDL has a higher affinity to proteoglycan receptors via a high plasma concentration its proteoglycan receptor by a factor of at least four (LDL / HDL$4), then LDL-influx into and LDL-retention compared to LDL [5] . Although the ratio (VLDL-IDLtime within the vascular wall become enhanced, and thus LDL) / HDL before medication was 8.5 in the high-risk an antiatherogenic barrier is broken through. This was the patient in our study, the protective efficacy of HDL can be case in our high risk patient. Accordingly, in the complete lipid fraction, the transition from the heterodimeric to the particles initiated through fluvastatin [35] . We are about to heterotrimeric nanoplaque complex, i.e. from the unravel these questions, which however, is outside the atheromatous to the calcified plaque, was promptly enscope of the present investigation. In agreement with hanced by 33.2% in normal serum calcium (Fig. 7) . The several clinical studies in which, under statins, a decline in HDL protection amounted to merely 20.3%. After a single atheromatous plaques has been demonstrated [32, 36, 37] , dose of fluvastatin, this protection against nanoplaques the dissolving effect of fluvastatin on nascent, even could be elevated to 58.6%. Correlated to this, the formacalcified, nanoplaques was illustrated at the end of the test tion of the ternary from the binary aggregational complex period (Figs. 1, 2, 5 and 6 ). Based on the background of 21 was diminished by 17.9% (Fig. 7) , that is fluvastatin recent clinical studies whereupon the Ca -content in the reduced the ternary compared to the binary nanoplaque coronary vascular wall as measured by electron beam building block by 51.1% altogether. These numbers impretomography is predictive of future cardiovascular events ssively substantiate the cooperative action of HDL and [38] , this finding of a disintegration of calcified nanopfluvastatin in the prevention of primary lesion generation.
laques may have high clinical relevance. In order to test the applicability of the biosensor model Summarizing, it should be stated that the pleiotropic more thoroughly, we investigated the efficacy of fluvaseffects of statins described so far, such as plaque stabilizatatin on arteriosclerotic nanoplaque formation with lipid tion [36] , antiinflammatory effects [39] , reduction of fractions that originated from high risk patients with thrombus formation [40] and removal of endothelial dyslipoproteinaemia and type 2 diabetes mellitus after a dysfunction [41] , are joined by a further pleiotropic effect, long-term treatment (2 months). Here, in addition, results that possibly has decisive prophylactic and therapeutic were presented with the VLDL / IDL / LDL and VLDL / importance for the lowering of cardiovascular risk under IDL / LDL / HDL fractions after acute treatment of a patient fluvastatin with respect to myocardial infarction and (1 day), whose cardiovascular risk consisted of diabetes stroke, independent of any decrease in LDL or increase in mellitus and a low HDL plasma level and whose lipid HDL concentrations [42, 43] . According to our thesis, concentrations had undergone no significant changes apfluvastatin could acutely intervene in the deranged control proximately 10 h after the intake of one fluvastatin 80 mg circuit at the blood-endothelium-matrix interface and tablet only (cf. Table 1 ). Therefore, possible effects of assist HDL in its vasculoprotective effect from an influvastatin could in no case be traced back to an influence creased LDL uptake and formation of ternary proteoglycan on the lipid concentrations [11, 34] . We could show that receptor-lipoprotein-calcium nanoplaques as well as neither adsorbed amount nor layer thickness of the ternary through their redissolving. The long-term effects of fluvasversus the binary nanoplaque complex were elevated at a tatin raised from the same high risk patient collective, 21 physiologic blood Ca concentration of 2.5 mmol / l (a which are accompanied by the usual changes in lipid reduction was even the case) (Figs. 3 and 7) and that also, concentrations and which will be presented in detail in 21 at all Ca concentrations used, calcified atheromatous another publication, have to be interpreted in the light of nanoplaques were reduced in formation and size in comthe immediate effects portrayed above. parison to untreated controls of the same patient (Figs. 4  and 8 ). Including the results after 2 months treatment into these considerations, there was a surprising finding. In A cknowledgements 21 normal serum Ca concentration, after 1 day of statin intake, an inhibitory effect on nanoplaque formation of on
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Since dialysis was repeatedly used during the reproces- 
